Home » Health » Flu and Corona Vaccination Demand Increases in Wolfratshausen District

Flu and Corona Vaccination Demand Increases in Wolfratshausen District

COVID Vaccination ‍Remains charged as RSV Shot Gains Acceptance, Bavarian⁤ Doctors Report

Bad‍ Tölz, Germany – While demand for influenza and‌ COVID-19 vaccinations is underway in the⁢ Bad Tölz-Wolfratshausen district, doctors report a stark contrast in public‌ acceptance, with lingering emotional responses to COVID-19 impacting uptake. Despite ​recommendations for vulnerable populations, the logistical challenges of administering⁢ the COVID-19 vaccine persist,‍ while a new ⁢vaccine against RSV (respiratory syncytial virus) ‌is being met with considerably less skepticism.

Family doctor Dr.⁤ Matthias Bohnenberger notes, “Everything that has to do with Corona is still emotionalized,”​ explaining the ‌difference ⁣in demand compared to influenza vaccination. He clarifies that COVID-19 vaccination‍ remains⁣ recommended for risk patients and those‌ in the​ medical sector. Dr. ⁢Lohse,​ a physician in Münsingen, echoes this sentiment, stating that while the virus “is not gone…you can compare the ‍extent with a second flu ⁣wave,” and ⁣confirms ⁤they⁣ are currently treating COVID-19 patients.

Pharmacy spokesman Christopher Hummel, in a press release, recommends the COVID-19 vaccine for individuals aged 60 and over, ⁤as well as those with chronic illnesses, advising individual consultation.

However, Bohnenberger highlights the ​logistical hurdles: “The vaccination still‌ does not exist individually. if you thaw a vaccine, you ​have to vaccinate six people on that day, otherwise vaccine breaks,” creating a‌ important organizational burden for ⁣practices. He expresses frustration with⁢ short-notice cancellations.

In contrast, the newly available RSV vaccine is gaining‌ traction. Bohnenberger ​describes it as “a sensible prevention measure before pneumonia that can be triggered by RSV viruses,” recommended and ‍covered by health insurance ​for those over 75 ‌and patients‌ over 60 with specific risk ‍factors. “Compared to this new vaccine, there is no great skepticism compared to Corona,” he states, adding ⁣that patients‌ have tolerated the ‍RSV vaccine well in his‍ practice.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.